Postgrad LIVE! Study Fairs

Southampton | Bristol

European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Anglia Ruskin University Featured PhD Programmes
Karlsruhe Institute of Technology Featured PhD Programmes

Small-molecule inhibitors of adenylate cyclases

  • Full or part time
  • Application Deadline
    Thursday, February 21, 2019
  • Competition Funded PhD Project (Students Worldwide)
    Competition Funded PhD Project (Students Worldwide)

Project Description

Inhibitors (modulators in general) of bacterial (e.g. from Bordetella pertussis and Bacillus anthracis) and/or human adenylate cyclases (ACs) have a great therapeutic potential in treatment of either infectious diseases or diseases as cancer, chronic pain, neurodegenerative disorders and asthma. The aim of the thesis will be design, synthesis and biological evaluation (SAR study) of novel inhibitors of ACs. The key group of compounds are structurally modified nucleosides and nucleotides.

How to apply

To apply for a PhD study at IOCB Prague, you must hold a Master’s degree (MSc) or the equivalent of the MSc in similar field (four or five year undergraduate degree). The application can be submitted before obtaining the Master’s degree, however, the applicant should obtain the degree within five months after the application deadline.

For more information visit our website “Call for PhD applications 2019”:

You can apply online via our application form


All general enquiries should be directed to Katerina Solcova (). Scientific enquiries can be addressed to the supervisor ().

Funding Notes

Regular monthly income of students at IOCB Prague varies depending on the faculty scholarship and supervisor's financial options.


1. Šmídková, M. et al.: Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis. Antimicrobial Agents and Chemotherapy 58: 664–671, 2014.
2. Břehová P. et al.: Design and synthesis of fluorescent acyclic nucleoside phosphonates as potent inhibitors of bacterial adenylate cyclases. ChemMedChem 11: 2534–2546, 2016.
3. Česnek M. et al.: Nucleobase modified adefovir (PMEA) analogues as potent and selective inhibitors of adenylate cyclases from Bordetella pertussis and Bacillus anthracis. ChemMedChem 13: 1779–1796, 2018.

Related Subjects

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.